You searched for Blood cancer

Podcast 1 Sep 2023

Beyond Biotech podcast 61 – Blood Cancer Awareness Month

On this week’s podcast, to recognize Blood Cancer Awareness Month, we have a conversation with Affimed's CMO, Andreas Harstrick, to talk about blood cancers, and what Affimed is doing to…

September 1, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

BioInvent International AB has been selected as partner of The Leukemia & Lymphoma Society’s Therapy Acceleration Program (LLS TAP). The program is aimed at advancing the company’s program to treat…

January 18, 2023 - 4 minutesmins - By Jim Cornall

blood cancer disease model, multi-omics, CAR-T, oncology

Deciphering blood cancer complexity with multi-omics and patient-relevant disease models

A new case of blood cancer gets diagnosed approximately every three minutes in Western countries. Although the last three decades have seen considerable progress in treating blood cancers, this heterogeneous…

December 5, 2022 - 7 minutesmins - By External Contributor

News and Trends 13 Oct 2022

T-cell therapy platform trial begins in adults with blood cancers

SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using Smart Immune’s ProTcell platform, has entered clinical testing. The trial is being sponsored and led by Great Paris…

October 13, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 18 Jul 2022

Positive results for drug combination used to treat rare blood cancer

Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib - a medication for the treatment of intermediate or high-risk myelofibrosis (MF) - has given positive results in a study. The…

July 18, 2022 - 3 minutesmins - By Liza Laws

News and Trends 5 Jul 2022

AstraZeneca adds to its treatments for blood cancer with $100M deal

AstraZeneca announced today (July 5) it has agreed to buy a company working on a cancer cure. The company will hand over $100 million for TeneoTwo, Inc. in an upfront…

July 5, 2022 - 2 minutesmins - By Liza Laws

Interview 28 Oct 2020

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks, such as long timelines and serious adverse reactions. As CEO…

October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Is Single-Cell Sequencing the Solution to Treating Aggressive Blood Cancers?

The landscape of precision medicine has changed dramatically over the years. The completion of the Human Genome Project in 2003 has greatly accelerated our understanding of individual genomes, leading to…

December 9, 2019 - 8 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 4 Dec 2017

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors suitable for bone marrow transplant to treat blood cancer. From its Amsterdam headquarters, Kiadis Pharma…

December 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Sep 2017

Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment

The FDA has backed Kiadis Pharma's lead blood cancer product by granting it the Regenerative Medicine Advanced Therapy designation. Kiadis Pharma, based in Amsterdam, develops products to make bone marrow transplants…

September 20, 2017 - 2 minutesmins - By Alex Dale

Interview 22 May 2017

Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer

Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing and discusses how the dutch biotech ecosystem has evolved. Arthur Lahr has been part of…

May 22, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2016

How is European Immuno-Oncology fighting Blood Cancer?

From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's edition of the American Society of Hematology (ASH) annual meeting features immuno-oncology therapies developed by…

December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Oct 2016

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some of the most promising technologies in immuno-oncology: TCR and checkpoint inhibitors. Adaptimmune is an immuno-oncology billion-euro…

October 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 May 2016

It’s Blood Cancer Day, how is Biotech fixing it?

Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers - which are…

May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro

msd cancer research uk monash crt merck australia

News and Trends 1 Feb 2016

New Discovery unites Australia, Germany and UK Against Blood Cancers

Cancer Research UK has teamed up with MSD (Merck) and the Wellcome Trust to co-develop some Inhibitors for both Cancerous and Non-cancerous blood disorders from the Australian Academia-Biotech Network. The Australian…

February 1, 2016 - 2 minutesmins - By Dani Bancroft

morphosys multiple myeloma immunooncology mor202

News and Trends 7 Dec 2015

Best-in-Class Label for Blood Cancer Trial by Billion Euro Biotech

Latest results of MorphoSys candidate for Multiple Myeloma show that it was Celgene's loss when it abandoned the phase I/IIa trial partnership on blood cancer. Announced at the American Society…

December 7, 2015 - 3 minutesmins - By Dani Bancroft

kesios myeloma imperial innovations london

News and Trends 2 Dec 2015

An Imperial College Based Start-Up Has Raised €27M in Series A for a Blood Cancer Drug

Kesios is a start-up Biotech based in London (UK) which has raised over €27M in a Series A funding round for its pipeline targeting the fight against multiple myeloma. A…

December 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Nov 2015

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers. Now their phase I clinical trial of belinostat (trade name Beleodaq) combined with chemo for…

November 11, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous)…

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 9 Mar 2023

Twisted blood vessels reveal cancer treatment success potential

Picture Health has announced plans to commercialize a new artificial intelligence (AI)-powered biomarker with the potential to transform the way doctors decide how to treat cancer. The advancement in cancer…

March 9, 2023 - 3 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering